FTW Holding ApS - CVR: 39873389

2022, EUR

15.06.2023

Bruttoresultat

26.055'

Primær drift

-73.000

Årets resultat

2.660'

Aktiver

34.198'

Kortfristede aktiver

4.076'

Egenkapital

34.127'

Afkastningsgrad

-0 %

Soliditetsgrad

100 %

Likviditetsgrad

+500%

Resultat

15.06.2023

Årsrapport	2022 15.06.2023	2021 01.07.2022	2020 06.07.2021	2019 03.09.2020	2018 12.06.2019
Nettoomsætning	90.419.000	90.419.000	90.419.000	90.419.000	90.419.000
Bruttoresultat	26.055.000	0	0	0	0
Bruttoresultat	11.477.000	11.477.000	11.477.000	11.477.000	11.477.000
Resultat af primær drift	-73.000	-36.000	-103.000	-22.000	1.716.000
Indtægter af kapitalandele (tilknyttede og associerede)	2.686.000	-17.000	62.000	4.789.000	513.000
Finansielle indtægter	59.000	112.000	187.000	194.000	86.000
Finansieringsomkostninger	-18.000	-24.000	-416.000	-1.000	-929.000
Andre finansielle omkostninger	0	0	0	0	0
Resultat før skat	2.653.000	-183.000	-457.000	4.766.000	494.000
Resultat	2.660.000	-173.000	-433.000	4.771.000	498.000
Forslag til udbytte	-1.614.000	-538.000	-1.613.000	0	0

Aktiver

15.06.2023

Årsrapport	2022 15.06.2023	2021 01.07.2022	2020 06.07.2021	2019 03.09.2020	2018 12.06.2019
Kortfristede varebeholdninger	0	0	0	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	0	0	0	0	0
Likvider	2.648.000	3.486.000	4.537.000	5.784.000	1.638.000
Kortfristede aktiver	4.076.000	4.598.000	6.395.000	6.387.000	802.000
Immaterielle aktiver og goodwill	31.070.000	3.978.000	29.151.000	2.323.000	2.614.000
Finansielle anlægsaktiver	0	27.341.000	27.936.000	27.536.000	0
Materielle aktiver	19.914.000	6.801.000	0	2.515.000	2.257.000
Langfristede aktiver	30.122.000	27.341.000	27.936.000	27.536.000	8.386.000
Aktiver	34.198.000	31.939.000	34.331.000	33.923.000	9.188.000

Aktiver

15.06.2023

Passiver

15.06.2023

Årsrapport	2022 15.06.2023	2021 01.07.2022	2020 06.07.2021	2019 03.09.2020	2018 12.06.2019
Forslag til udbytte	1.614.000	538.000	1.613.000	0	0
Egenkapital	34.127.000	31.785.000	33.221.000	33.293.000	8.373.000
Hensatte forpligtelser	0	0	6.008.000	0	0
Langfristet gæld til banker	0	1.838.000	0	0	0
Anden langfristet gæld	0	2.780.000	1.251.000	0	147.000
Leverandører af varer og tjenesteydelser	84.351.000	66.903.000	61.992.000	16.375.000	11.510.000
Kortfristede forpligtelser	71.000	154.000	1.110.000	630.000	815.000
Gældsforpligtelser	0	154.000	1.110.000	0	815.000
Forpligtelser	0	154.000	1.110.000	0	815.000
Passiver	34.198.000	31.939.000	34.331.000	33.923.000	9.188.000

Passiver

15.06.2023

Nøgletal

15.06.2023

Årsrapport	2022 15.06.2023	2021 01.07.2022	2020 06.07.2021	2019 03.09.2020	2018 12.06.2019
Afkastningsgrad	-0,2 %	-0,1 %	-0,3 %	-0,1 %	18,7 %
Dækningsgrad	28,8 %	Na.	Na.	Na.	Na.
Resultatgrad	2,9 %	-0,2 %	-0,5 %	5,3 %	0,6 %
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.	Na.
Egenkapitals-forretning	7,8 %	-0,5 %	-1,3 %	14,3 %	5,9 %
Payout-ratio	60,7 %	-311,0 %	-372,5 %	Na.	Na.
Gældsdæknings-nøgletal	-405,6 %	-150,0 %	-24,8 %	-2.200,0 %	184,7 %
Soliditestgrad	99,8 %	99,5 %	96,8 %	98,1 %	91,1 %
Likviditetsgrad	5.740,8 %	2.985,7 %	576,1 %	1.013,8 %	98,4 %

Resultat

15.06.2023

Gæld

15.06.2023

Årsrapport

15.06.2023

Nyeste:01.01.2022- 31.12.2022(offentliggjort: 15.06.2023)

Oplysning om pantsætninger og sikkerhedsstillelser:Mortgage and collateralFor information on mortgage and collateral for the Group, please refer back to the note 22 in the consolidated financial statements. The parent company has no pledges or collaterals.FTW Holding ApS has pledged the shares in Wagner Family Holding ApS as security for the bank loans within the Group. For detailed desciption of terms and amounts please refer back to note 22 in the consolidated financial statements.

Beretning

15.06.2023

Dato for ledelsens godkendelse af årsrapporten:2023-05-04

Ledelsespåtegning:Statement by Management on the annual report

Beskrivelse af usikkerhed ved indregning eller måling:Material recognition and measurement uncertaintiesIn preparing the consolidated financial statements, Management makes various accounting estimates and assumptions which form the basis of the presentation, recognition and measurement of the Group's assets and liabilities. Determining the carrying amounts of certain assets and liabilities requires estimates and assumptions concerning future events. Estimates and assumptions are based on historical experience and other factors, which Management assesses to be reasonable, but which by their nature involve uncertainty and unpredictability. These assumptions may have to be revised, and unexpected events or circumstances may occur. FTW Holding Group is subject to risks and uncertainties that may lead to the actual results differing from these estimates, both positively and negatively. Specific risks are discussed in the Management review in the section above. Outlook for 2023Despite the geopolitical unrest and volatile energy in financial markets, we expect the pharmaceutical industry generally remains moderately impacted, and that favourable long- term trends will support robust growth in prescriptions and pharmaceutical services. For 2023, Management expects that the FTW Group will achieve organic revenue growth of around 6-11%. The FTW Group revenue is expected to be within the range of EUR 1,090-1,140 million and the EBITDA margin is expected to be within the range of 2. 2%-2. 6% in 2023. The FTW Group management expects that the activities in FTW Invest and DayDose will have a limited impact on this range.

Beskrivelse af usædvanlige forhold, der kan have påvirket indregningen eller målingen:Unusual mattersNo unusual matters occurred in the financial year which have had a material effect on the Group and Parent Company’s financial position.

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, the Executive Management have discussed and approved the Annual Report of FTW Holding ApS for the financial year 1 January– 31 December 2022.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:Management’s reviewManagement’s reviewFTW Holding ApS was established 15 September 2018. The purpose of the company is to hold the shares in FTW Invest ApS and the majority of the shares in Wagner Family Holding ApS, which owns the majority of shares in Abacus Medicine A/S (Abacus Medicine Group) and DayDose ApS. The activities within the Group consist mainly of the activities within the Abacus Medicine Group, accordingly the business review reflects primarily the Abacus Medicine Group’s business. Abacus Medicine Group is established as one of the market leaders in parallel distribution. We are growing within pharmaceutical services and also operate as a medicine wholesaler. The result for the year in the consolidated financial statements ended at a profit of EUR 5. 1 million, which is satisfactory. Restrictions related to COVID-19 were lifted in most European countries, and the order patterns for pharmaceutical products gradually returned to more normal levels. Despite the outbreak of the war in Ukraine and the following increase in inflation and raw material prices, the pharmaceutical industry generally proved moderately impacted and all parts of the Abacus Medicine Group delivered solid organic growth. The Abacus Medicine parallel distribution business saw growth and profitability in most markets. The service offerings of Abacus Medicine Pharma Services attracted new customers and led to strong revenue growth. Pluripharm continued to attract new pharmacy customers and gain market share in the retail market, which kept them competitive in the Dutch market for pharmaceutical wholesaling. As a result of the above, revenue for the Abacus Medicine Group grew 9% in 2022 to EUR 1,024 million against 941 million in 2021. EBITDA for the Abacus Medicine Group grew 58% in 2022 to 26. 2 million against 16. 6 million in 2021. This resulted in an EBITDA-margin of 2. 6%. The development was in line with the Outlook. This is the Group's highest revenue and EBITDA ever. Profit for the year for the Abacus Medicine Group was EUR 5. 8 million (2021: EUR 0. 4 million), which was satisfactory. The result for DayDose ApS ended with a loss of DKK 0. 2 million. The average number of full time employees was 1,140 in 2022.